Professor | Qin Liu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Qin Liu
Contact Information	liuqin@nju.edu.cn
Language ability	Chinese, English
Province	Jiangsu

Upload Avatar (500 x 500)

Name

Qin Liu

Contact Information

liuqin@nju.edu.cn

Language ability

Chinese, English

Province

Jiangsu

University/Lab Affiliation and Title	Nanjing University
Faculty	Medical School
Academic Background & Achievements	PhD: Nanjing University Medical School Jiangsu Province '333' Project third-level training object Jiangsu Province Young Medical Key Talent
Awards	2021: First Prize of Jiangsu Province Medical New Technology Introduction Award for the establishment and application of gastric cancer-specific immunotherapy technology based on neoantigens 2019: First Prize of Jiangsu Province Science and Technology Progress Award for new discoveries and translational research in precision medicine for gastric cancer based on molecular markers 2019: First Prize of Jiangsu Province Medical Science and Technology Award for precision individualized treatment of gastric cancer 2016: First Prize of Jiangsu Province Medical New Technology Introduction Award for the individualized application of nanomedicine based on physiological drug resistance of malignant tumors 2015: Ministry of Education Science and Technology Progress Award for basic clinical research on new systems for targeted nanomedicine delivery for gastric cancer 2015: Second Prize of Jiangsu Province Science and Technology Progress Award for basic clinical research on new systems for targeted nanomedicine delivery for gastric cancer 2015: Third Prize of Chinese Medical Award for basic clinical research on new systems for targeted nanomedicine delivery for gastric cancer 2015: Second Prize of Jiangsu Province Medical Science and Technology Award for basic clinical research on new systems for targeted nanomedicine delivery for gastric cancer

University/Lab Affiliation and Title

Nanjing University

Faculty

Medical School

Academic Background & Achievements

PhD: Nanjing University Medical School
Jiangsu Province '333' Project third-level training object
Jiangsu Province Young Medical Key Talent

Awards

2021: First Prize of Jiangsu Province Medical New Technology Introduction Award for the establishment and application of gastric cancer-specific immunotherapy technology based on neoantigens
2019: First Prize of Jiangsu Province Science and Technology Progress Award for new discoveries and translational research in precision medicine for gastric cancer based on molecular markers
2019: First Prize of Jiangsu Province Medical Science and Technology Award for precision individualized treatment of gastric cancer
2016: First Prize of Jiangsu Province Medical New Technology Introduction Award for the individualized application of nanomedicine based on physiological drug resistance of malignant tumors
2015: Ministry of Education Science and Technology Progress Award for basic clinical research on new systems for targeted nanomedicine delivery for gastric cancer
2015: Second Prize of Jiangsu Province Science and Technology Progress Award for basic clinical research on new systems for targeted nanomedicine delivery for gastric cancer
2015: Third Prize of Chinese Medical Award for basic clinical research on new systems for targeted nanomedicine delivery for gastric cancer
2015: Second Prize of Jiangsu Province Medical Science and Technology Award for basic clinical research on new systems for targeted nanomedicine delivery for gastric cancer

Areas of Focus	Therapeutic vaccines for malignant tumors Construction and application of new tumor immunotherapeutic drugs
Publications	Bifunctional Fusion Membrane-Based Hydrogel Enhances Antitumor Potency of Autologous Cancer Vaccines by Activating Dendritic Cells, Ke Y, Zhu J, Chu Y, Cen L, Fu Y, Fan X, Shao J, Li R, Yu L, Liu B, Liu Q, 2022 Benefits of an immunogenic personalized neoantigen nanovaccine in patients with high-risk gastric/gastroesophageal junction cancer, Liu Q, Chu Y, Shao J, Qian H, Yang J, Wei J, Liu B, 2022 Versatile Protein Coronation Approach with Multiple Depleted Serum for Creating Biocompatible, Precision Nanomedicine, Wang C, Xue M, Liu X, Chen J, Jiang M, Zheng L, Ma R, Ding C, Tao Y, Zhang H, Liu Q, Da Huo, 2022 Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles, Liu Q, Li R, Qian H, Wei J, Xie L, Shen J, Yang M, Qian X, Yu L, Jiang X, Liu B, 2013 Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma, Chu Y, Qian L, Ke Y, Feng X, Chen X, Liu F, Yu L, Zhang L, Tao Y, Xu R, Wei J, Liu B, Liu Q, 2022 Personalized cancer neoantigen vaccines come of age, Chu Y, Liu Q, Wei J, Liu B, 2018 An auristatin-based peptide-drug conjugate targeting Kita-Kyushu lung cancer antigen 1 for precision chemoradiotherapy in gastric cancer, Chen X, Liu F, Yu X, Li L, Yan J, Chen X, Liu Q, Liu B, 2022 Tumor eradicated by combination of imiquimod and OX40 agonist for in situ vaccination, Chu Y, Li R, Qian L, Liu F, Xu R, Meng F, Ke Y, Shao J, Yu L, Liu Q, Liu B, 2021 Superior Antitumor Efficacy of IFN-α2b-Incorporated Photo-Cross-Linked Hydrogels Combined with T Cell Transfer and Low-Dose Irradiation Against Gastric Cancer, Liu Q, Zhang D, Qian H, Chu Y, Yang Y, Shao J, Xu Q, Liu B, 2020 Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer, Zhang D, Chu Y, Qian H, Qian L, Shao J, Xu Q, Yu L, Li R, Zhang Q, Wu F, Liu B, Liu Q, 2020

Areas of Focus

Therapeutic vaccines for malignant tumors
Construction and application of new tumor immunotherapeutic drugs

Publications

Bifunctional Fusion Membrane-Based Hydrogel Enhances Antitumor Potency of Autologous Cancer Vaccines by Activating Dendritic Cells, Ke Y, Zhu J, Chu Y, Cen L, Fu Y, Fan X, Shao J, Li R, Yu L, Liu B, Liu Q, 2022
Benefits of an immunogenic personalized neoantigen nanovaccine in patients with high-risk gastric/gastroesophageal junction cancer, Liu Q, Chu Y, Shao J, Qian H, Yang J, Wei J, Liu B, 2022
Versatile Protein Coronation Approach with Multiple Depleted Serum for Creating Biocompatible, Precision Nanomedicine, Wang C, Xue M, Liu X, Chen J, Jiang M, Zheng L, Ma R, Ding C, Tao Y, Zhang H, Liu Q, Da Huo, 2022
Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles, Liu Q, Li R, Qian H, Wei J, Xie L, Shen J, Yang M, Qian X, Yu L, Jiang X, Liu B, 2013
Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma, Chu Y, Qian L, Ke Y, Feng X, Chen X, Liu F, Yu L, Zhang L, Tao Y, Xu R, Wei J, Liu B, Liu Q, 2022
Personalized cancer neoantigen vaccines come of age, Chu Y, Liu Q, Wei J, Liu B, 2018
An auristatin-based peptide-drug conjugate targeting Kita-Kyushu lung cancer antigen 1 for precision chemoradiotherapy in gastric cancer, Chen X, Liu F, Yu X, Li L, Yan J, Chen X, Liu Q, Liu B, 2022
Tumor eradicated by combination of imiquimod and OX40 agonist for in situ vaccination, Chu Y, Li R, Qian L, Liu F, Xu R, Meng F, Ke Y, Shao J, Yu L, Liu Q, Liu B, 2021
Superior Antitumor Efficacy of IFN-α2b-Incorporated Photo-Cross-Linked Hydrogels Combined with T Cell Transfer and Low-Dose Irradiation Against Gastric Cancer, Liu Q, Zhang D, Qian H, Chu Y, Yang Y, Shao J, Xu Q, Liu B, 2020
Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer, Zhang D, Chu Y, Qian H, Qian L, Shao J, Xu Q, Yu L, Li R, Zhang Q, Wu F, Liu B, Liu Q, 2020

Malignant Tumors Therapeutic Vaccines Tumor Immunotherapy New Drugs Clinical Practice Basic Research Translational Research Personalized Neoantigen Nanovaccine Drug Resistance

Yongchang Wei - Wuhan University

Wanjun Ding - Wuhan University

Wang Zhiliang - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us